Send me a link:

*Text messaging rates may apply.

 Dow Down 0.19% Nasdaq Up 0.45%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
163.68 Jul 30, 4:00PM EDT
Prev Close:163.68
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:196.95
Beta:0.51
Earnings Date:Oct 22 - Oct 27 (Est.)
Day's Range:N/A - N/A
52wk Range:100.89 - 185.43
Volume:0
Avg Vol (3m):1,205,060
Market Cap:32.38B
P/E (ttm):98.96
EPS (ttm):1.65
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALXN

Comparison

Symbol% ChgMkt Cap
ALXN 0.00%32.38B
AMGN98.68B
BAX41.29B

Key Statistics

Forward P/E (1 yr):28.32
P/S (ttm):16.85
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :5.00
Quarterly EPS Est (Sep-14) :1.16
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):1.05

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback